FTO Is Not About Zero Risk: It Is About Whether the Remaining Risk Is Worth Taking

Management often wants an FTO to deliver a simple answer: “No patent risk—safe to launch.” A responsible FTO usually cannot make that promise. Its real value is to identify the known risks, explain the uncertainties, and give the business enough information to decide which risks are worth taking and which are not.

Why Zero-Risk FTO Is Not a Realistic Standard

Patent searching has unavoidable time and information limits. Unpublished applications cannot be found in public patent databases. Published applications may still be amended during prosecution. Product designs evolve. Even when a relevant patent is identified, reasonable people may disagree about claim construction, product operation, or the completeness of the technical record.

WIPO’s FTO guidance states the point directly: an absolute guarantee of freedom to operate will never be attainable. The practical objective is to identify and minimize risk before commercial launch.

That limitation does not make FTO weak. It defines what the analysis is actually for. Companies enter new markets without eliminating every competitive, regulatory, contractual, and litigation risk. Patent risk is similar: it can be identified, evaluated, reduced, transferred, monitored, or sometimes accepted—but not always erased.

Separate the Risk Before Trying to Rate It

A useful FTO does not begin and end with a color code. It should separate different kinds of uncertainty:

Which patents and pending applications are closest to the product?
Which claims potentially reach commercially important functions?
Which conclusions depend on incomplete product information?
Which features can be modified without damaging the product’s value?
Which risks may be addressed through licensing, invalidity analysis, non-infringement positions, or ongoing monitoring?

Once those issues are separated, the business has options. A peripheral feature with little customer value may be removed or replaced. A patent covering a core selling point may be harder to design around, but a commercially acceptable license may preserve the feature. Another patent may have a short remaining term, limited expected exposure, or a pending claim set that requires monitoring rather than immediate redesign.

Commercial Exposure and Legal Infringement Are Different Questions

Business factors affect the consequences of a risk; they do not change the legal infringement analysis. A patent nearing expiration does not make pre-expiration acts automatically noninfringing. Low sales volume does not change whether every limitation of a claim is present. Inventory controls may reduce exposure, but they do not rewrite the claim.

This distinction matters because “high,” “medium,” and “low” are not statutory traffic lights. They are internal ways to organize and communicate analysis. A high-risk item does not necessarily mean “stop the project.” Strong non-infringement arguments, significant invalidity evidence, or a fast design-around may justify continuing. A low-risk item does not mean “safe forever.” A supplier change, product revision, newly issued patent, or entry into another country can make the earlier conclusion obsolete.

Risk level is the start of the decision

Management still needs to know which claim creates the concern, how likely the dispute is to matter, what the downside could be, what can be redesigned, whether licensing is realistic, and what evidence supports non-infringement or invalidity.

The Same Patent Risk Can Produce Different Business Decisions

A medium-risk issue in a consumer product that can be redesigned in two weeks is not the same business problem as a medium-risk issue in a medical product after substantial tooling, clinical, certification, or market-entry investment. Patent risk cannot be evaluated in isolation from the economics of the product.

The relevant comparison is often broader:

What revenue or strategic value does launch create?
What will a design-around cost, and what performance will be lost?
What market opportunity is lost if launch is delayed?
Is licensing practical and economically rational?
What is the worst-case impact of an injunction, damages award, litigation cost, channel disruption, or inventory problem?

For U.S. patents, the legal backdrop matters. Under 35 U.S.C. §284, damages upon a finding of infringement must be adequate to compensate for the infringement and not less than a reasonable royalty, and a court may increase damages up to three times. Under §285, reasonable attorney fees may be awarded to the prevailing party in exceptional cases. Section 286 generally bars recovery for infringement committed more than six years before the complaint or counterclaim.

Accepting a Known Risk Is Not the Same as Ignoring It

A company may decide to proceed after identifying a patent risk. That does not mean the FTO failed. In many cases, the fact that the risk was identified, analyzed, documented, and paired with alternatives is exactly what risk management is supposed to accomplish.

But “commercially acceptable risk” should not become a euphemism for knowingly ignoring a serious infringement problem. The Supreme Court’s Halo Electronics v. Pulse Electronics decision explains that enhanced damages are aimed at egregious infringement behavior rather than ordinary cases. Knowledge of a patent by itself does not automatically produce treble damages, but what a company knew and how it responded can matter in a later willfulness dispute.

For material risks, companies should preserve the product record, claim analysis, decision basis, and follow-up actions. Continuing should rest on a credible non-infringement, invalidity, licensing, or design-around position—not on an assumption that the patent owner will never notice.

FTO Also Identifies Risks Not Worth Taking

The analysis can create value by showing where the company should not spend its risk budget. An easily modified component may not justify years of patent exposure. A marginal feature may not justify an expensive license. A country with limited forecast sales and dense blocking rights may not justify immediate entry.

Avoiding those risks can be more valuable than obtaining a report that simply labels the overall project “low risk.”

What a Good FTO Should Deliver

A good FTO does not make the management decision. It should make the decision better. That means stating the known patents, relevant product facts, claim-analysis basis, information gaps, and available options clearly enough that management understands the consequences of each path.

Companies cannot reduce all patent risk to zero. They can, however, consciously take risks that are supported by sound analysis and commercial logic while avoiding risks that create little corresponding value. That is the practical value FTO can provide.